Skip to main content
Equibles

STATE STREET CORP

Position in OCGN — Ocugen, Inc.

CIK 93751 BOSTON, MA
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$32,848,039
+$15,344,994 QoQ
Shares Held
21,469,307
+122.0% QoQ
Ownership
6.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 8% Shared 0% None 92%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. OCGN ranks #143 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in OCGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,848,039 21,469,307
2026-03-31 $17,503,045 9,670,191
2025-12-31 $5,371,296 3,978,738
2025-09-30 $2,209,264 1,355,377
2025-06-30 $1,298,751 1,338,919
2025-03-31 $4,188,020 5,932,041
2024-12-31 $4,722,216 5,866,108
2024-09-30 $15,697,920 15,824,517
2024-06-30 $22,903,762 14,776,621
2024-03-31 $1,569,030 956,726
2023-12-31 $480,599 835,826
2023-09-30 $352,650 881,626
2023-06-30 $478,722 881,626
2023-03-31 $5,215,336 6,114,111
2022-12-31 $39,157,331 30,121,024
2022-09-30 $46,292,819 26,007,202
2022-06-30 $69,502,737 30,617,946
2022-03-31 $96,207,223 29,153,704
2021-12-31 $63,780,166 14,017,619
2021-09-30 $81,259,764 11,317,516
2021-06-30 $87,173,439 10,855,970
2021-03-31 $34,180,418 5,033,935
2020-12-31 $18,849 10,300